top of page

TransHeps

Serving global Pharma Drug Developers and Regulators by providing the MetaHeps assay as a decision-enabling drug development tool for DILI causality assessment in clinical studies

Using the power of the MetaHeps assay

AdobeStock_718024539.jpeg
Element-orange_0,5x.png

The leadership team

Armin Wolf, CEO
Prof. Armin Wolf, PhD

CEO and Founder

Martin Birk, CFO/COO
Martin Birk, 3xMSc

CFO/COO and Founder

Michele Visentin, VP of Science
Michele Visentin, PhD

VP Science and
Co-Founder

Sophia Samodelov, VP of Business
Sophia Samodelov, PhD

VP Business and
Co-Founder 

Contact Us

Get in touch to find out more about our TransHeps technology

Address

Lab address:

TransHeps AG (BIO-TECHNOPARK)
Room 101-104
Wagistrasse 14, 8952 Schlieren, Zurich, Switzerland
 

Legal address:

TransHeps AG

Kirchstrasse 1, 8104 Weiningen, Zurich, Switzerland

Email

customerservice@transheps.com

Social Media

  • LinkedIn

Thanks for submitting!

bottom of page